A landmark trial presented at ESCMID Global 2026 shows that improving oral hygiene for hospital patients can reduce the risk ...

Many calves develop pneumonia days before showing symptoms. Lung ultrasounds are helping veterinarians detect the hidden ...

In the 2000s, when the AIDS pandemic hit South Africa, we were seeing a lot of children dying from HIV. That was just before ...

Insmed said its phase 3b Encore study of Arikayce in mac lung disease met its main goal and all multiplicity-controlled secondary culture-conversion endpoints, with the clearest gains showing up in ...

In March 2026, Insmed reported positive Phase 3b ENCORE results showing ARIKAYCE added to standard multidrug therapy improved symptoms and culture conversion in patients with MAC lung disease who were ...

Insmed Incorporated, a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, announced ...

"These results are an exciting win for patients living with MAC lung disease and a powerful validation of ARIKAYCE's ability to deliver real clinical benefit as part of a multidrug treatment regimen," ...

—The Study Met Primary and All Multiplicity-Controlled Secondary Culture Conversion Endpoints, Demonstrating Statistically Significant and Clinically Meaningful Improvements in Respiratory Symptom ...

Doctors in Chicago saved the life of a young Missouri man with a rare infection that had liquefied his lungs, hooking him up to what they have called a total artificial lung. The patient, whose name ...

We present a case of concurrent pulmonary aspergillosis and tuberculosis in a 53-year-old male, treated with voriconazole and rifapentine. In this case, co-administration with rifapentine resulted in ...